LCB-1892

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLCB-1892
Drug Alias NameLCB-1892
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainEdemaInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono
Active IndicationsN/A
Inactive IndicationsPainEdemaInflammation

Other Information

ATC CodeN/A
Related LinksN/A